SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001683168-23-008149
Filing Date
2023-11-15
Accepted
2023-11-14 19:57:31
Documents
52

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT coeptis_s1.htm   iXBRL S-1 2056162
2 OPINION OF MEISTER SEELIG & FEIN PLLC coeptis_ex0501.htm EX-5.1 17682
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM coeptis_ex2301.htm EX-23.1 1693
4 CALCULATION OF FILING FEE TABLES coeptis_ex107.htm EX-FILING FEES 20257
5 GRAPHIC image_001.jpg GRAPHIC 12238
6 GRAPHIC image_002.jpg GRAPHIC 1041
7 GRAPHIC image_004.jpg GRAPHIC 2415
  Complete submission text file 0001683168-23-008149.txt   5988807

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE coep-20230930.xsd EX-101.SCH 17353
9 XBRL CALCULATION FILE coep-20230930_cal.xml EX-101.CAL 42987
10 XBRL DEFINITION FILE coep-20230930_def.xml EX-101.DEF 41957
11 XBRL LABEL FILE coep-20230930_lab.xml EX-101.LAB 174604
12 XBRL PRESENTATION FILE coep-20230930_pre.xml EX-101.PRE 134554
46 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_s1_htm.xml XML 1170859
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-275558 | Film No.: 231408728
SIC: 2836 Biological Products, (No Diagnostic Substances)